Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Intervention Indication Therapeutic Area Year Actions
Blinatumomab with chemotherapy for frontline consolidation treatment of Philadelphia chromosome negative, measurable residual disease negative, B-lineage acute lymphoblastic leukaemia Blinatumomab (Blincyto) , Chemotherapy Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2024 View  |  Download
Blinatumomab (Blincyto) for First Relapsed/Refractory, B-precursor, Acute Lymphoblastic Leukaemia, in Children and Adolescents Blinatumomab (Blincyto) Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2017 View  |  Download
Bis-choline tetrathiomolybdate for Wilson's disease Bis-choline tetrathiomolybdate (Decuprate; ATN-224; WTX101; ALXN1840) Wilson's disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2021 View  |  Download
Biotin for Adrenomyeloneuropathy without cerebral involvement Biotin (MD1003; Qizenday; Vitamin B7) Adrenomyeloneuropathy (AMN) Genetic Disorders , Neurology 2017 View  |  Download
Bintrafusp alfa for locally advanced or metastatic biliary tract cancer – second-line Bintrafusp alfa (M7824; GSK4045154) Biliary tract cancer Gastrointestinal Cancer 2020 View  |  Download
Bintrafusp alfa for advanced, unresectable cervical cancer Bintrafusp alfa (M7824; GSK4045154) Cervical cancer Female Reproductive Cancer 2021 View  |  Download
Bimekizumab for non-radiographic axial spondyloarthritis Bimekizumab (UCB4940) Axial spondyloarthritis Rheumatology 2021 View  |  Download
Bimekizumab for moderate to severe chronic plaque psoriasis Bimekizumab (UCB4940) Plaque psoriasis Dermatology 2019 View  |  Download
Bimekizumab for Hidradenitis Suppurativa Bimekizumab (UCB4940) Hidradenitis suppurativa (HS) Dermatology 2022 View  |  Download
Bimekizumab for ankylosing spondylitis Bimekizumab (UCB4940) Ankylosing spondylitis Musculoskeletal System 2021 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications